Research programme: interleukin-4 partial receptor agonists - Serodus

Drug Profile

Research programme: interleukin-4 partial receptor agonists - Serodus

Alternative Names: Ph8; SER-130; SER-130-AMI

Latest Information Update: 13 Jan 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Phlogo
  • Developer Serodus
  • Class Peptides
  • Mechanism of Action Interleukin 4 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Myocardial infarction

Most Recent Events

  • 09 Oct 2013 Preclinical trials in Myocardial infarction in Norway (Parenteral) before October 2013
  • 10 Jul 2013 Early research in Myocardial infarction in Denmark (Parenteral) before July 2013
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top